VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 13, 2007) - ALDA Pharmaceuticals Corp. (“ALDA”) (TSX VENTURE:APH) announces that Brand Institute, Inc. has been selected to assist with marketing efforts in the US and internationally. Dr. Terrance Owen, President & CEO comments, “As we make progress with the development of retail and therapeutic applications of the T36® technology, a strong US and international presence is important. ALDA needs to align its marketing efforts with its anticipated European and FDA product registrations and the proposed listing of its shares in the US. Due to their strong US and international presence, we have selected Brand Institute, Inc. to work with us so that ALDA can achieve success in its targeted markets.”
